Daniel P Kelly Selected Research

Daniel P Kelly Research Topics

Disease

18	Heart Failure 01/2022 - 04/2002
9	Cardiomyopathies (Cardiomyopathy) 01/2013 - 01/2002
7	Obesity 01/2019 - 02/2005
7	Insulin Resistance 01/2019 - 08/2003
6	Cardiomegaly (Heart Hypertrophy) 11/2014 - 04/2002
5	Hypertension (High Blood Pressure) 02/2021 - 01/2003
5	Mitochondrial Diseases (Mitochondrial Disease) 11/2019 - 01/2005
4	Hypertrophy 01/2019 - 01/2002
3	Inflammation (Inflammations) 11/2022 - 01/2021
3	Ketosis 01/2022 - 01/2020
3	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 05/2017
3	Critical Illness (Critically Ill) 01/2022 - 01/2017
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2013 - 07/2002
3	Myocardial Ischemia (Ischemic Heart Diseases) 09/2010 - 01/2006
3	Diabetes Mellitus 01/2010 - 01/2002
3	Diabetic Cardiomyopathies 12/2004 - 01/2002
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 10/2010
2	Muscular Atrophy (Muscle Atrophy) 01/2020 - 11/2019
2	Melanoma (Melanoma, Malignant) 01/2019 - 12/2014
2	Paralysis (Palsy) 07/2016 - 02/2014
2	Ventricular Dysfunction 04/2011 - 01/2002
2	Reperfusion Injury 12/2007 - 01/2006
2	Ischemia 12/2007 - 01/2006
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2022
1	Tracheitis 01/2021
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021
1	Atrophy 11/2019
1	Fibrosis (Cirrhosis) 10/2019
1	Aortic Valve Insufficiency (Aortic Regurgitation) 10/2018
1	Shock 05/2017
1	Coma (Comas) 05/2017
1	Lactic Acidosis 05/2017
1	Parkinson Disease (Parkinson's Disease) 04/2015
1	Premature Aging 07/2014
1	Esophageal Atresia 02/2014
1	Barth Syndrome 01/2014
1	Muscular Diseases (Myopathy) 06/2013

Drug/Important Bio-Agent (IBA)

19	PPAR alphaIBA 02/2013 - 01/2002
17	Fatty Acids (Saturated Fatty Acids)IBA 11/2018 - 01/2002
12	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 01/2002
7	KetonesIBA 01/2022 - 02/2016
7	LipidsIBA 11/2019 - 02/2003
6	EnzymesIBA 02/2016 - 04/2002
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2019 - 01/2002
4	Insulin (Novolin)FDA Link 11/2018 - 09/2005
4	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2017 - 04/2002
4	Proteins (Proteins, Gene)FDA Link 11/2014 - 11/2003
3	Pharmaceutical PreparationsIBA 01/2019 - 10/2010
2	EstersIBA 01/2022 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 07/2008
2	ProteomeIBA 01/2022 - 01/2020
2	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2020 - 02/2016
2	Lysine (L-Lysine)FDA Link 01/2020 - 02/2016
2	CalciumIBA 11/2019 - 10/2019
2	PPAR gammaIBA 02/2013 - 03/2004
2	CytokinesIBA 01/2013 - 09/2005
2	Biological ProductsIBA 10/2011 - 03/2006
2	Triglycerides (Triacylglycerol)IBA 09/2005 - 02/2003
2	Transcription Factors (Transcription Factor)IBA 12/2004 - 04/2002
1	Fluorine-18IBA 11/2022
1	Nonesterified Fatty Acids (NEFA)IBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	SaltsIBA 02/2021
1	Acetates (Acetic Acid Esters)FDA Link 02/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Ketone BodiesIBA 01/2021
1	Oxygen (Dioxygen)IBA 03/2020
1	Sodium-Glucose Transport ProteinsIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2019
1	Messenger RNA (mRNA)IBA 10/2018
1	empagliflozinIBA 08/2017
1	TabletsIBA 05/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 05/2017
1	Carbamazepine (Tegretol)FDA LinkGeneric 05/2017
1	barbituric acid (barbiturate)IBA 05/2017
1	Hydroxybutyrate Dehydrogenase (3 Hydroxybutyrate Dehydrogenase)IBA 02/2016
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 02/2016
1	SynucleinsIBA 04/2015
1	AntioxidantsIBA 04/2015
1	CarbonIBA 11/2014
1	proto-oncogene proteins pimIBA 07/2014
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2014
1	Cardiolipins (Cardiolipin)IBA 01/2014
1	MicroRNAs (MicroRNA)IBA 06/2013

Therapy/Procedure

9	Therapeutics 01/2022 - 12/2007
2	Ketogenic Diet 11/2022 - 01/2022
2	Mechanical Ventilators (Ventilator) 01/2021 - 07/2016
2	Artificial Respiration (Mechanical Ventilation) 01/2021 - 01/2019
2	Bed Rest (Bedrest) 01/2020 - 11/2019
2	Central Venous Catheters 07/2016 - 02/2014
1	Extracorporeal Membrane Oxygenation 01/2022
1	Noninvasive Ventilation 01/2019
1	Immunomodulation 01/2017
1	Thoracotomy 07/2016
1	Ligation 01/2015
1	Catheters 02/2014
1	Length of Stay 02/2014